首页> 外文期刊>World journal of gastroenterology : >Pathologic complete response confirmed by surgical resection for liver metastases of gastrointestinal stromal tumor after treatment with imatinib mesylate.
【24h】

Pathologic complete response confirmed by surgical resection for liver metastases of gastrointestinal stromal tumor after treatment with imatinib mesylate.

机译:用伊马替尼甲壳酸伊替尼处理后胃肠道肿瘤肝转移肝转移的手术切除,确认病理完全反应。

获取原文
获取原文并翻译 | 示例
           

摘要

A 39-year-old male underwent distal gastrectomy for a high grade gastrointestinal stromal tumor (GIST). Computed tomography (CT) and magnetic resonance imaging (MRI) 107 mo after the operation, revealed a cystic mass (14 cm in diameter) and a solid mass (9 cm in diameter) in the right and left lobes of the liver, respectively. A biopsy specimen of the solid mass showed a liver metastasis of GIST. The patient received imatinib mesylate (IM) treatment, 400 mg/day orally. Following the IM treatment for a period of 35 mo, the patient underwent partial hepatectomy (S4 + S5). The effect of IM on the metastatic lesions was interpreted as pathologic complete response (CR). Pathologically verified cases showing therapeutic efficacy of IM have been rarely reported.
机译:一个39岁的男性接受了高级胃肠间质瘤(GIST)的远端胃切除术。 在操作后,计算断层扫描(CT)和磁共振成像(MRI)107mo,揭示了肝脏左右叶片的囊性质量(直径为14cm)和固体质量(直径为9cm)。 固体质量的活检标本显示了GIST的肝脏转移。 患者接受了伊马替尼甲磺酸盐(IM)处理,口服400毫克/天。 在IM治疗后,35Mo的时间,患者接受部分肝切除术(S4 + S5)。 IM对转移性病变的影响被解释为病理完全反应(Cr)。 病理验证的病例已经很少报道了IM的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号